focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAgronomics Regulatory News (ANIC)

Share Price Information for Agronomics (ANIC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 8.60
Bid: 8.50
Ask: 8.70
Change: 0.00 (0.00%)
Spread: 0.20 (2.353%)
Open: 8.60
High: 8.60
Low: 8.45
Prev. Close: 8.60
ANIC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Net Asset Value(s)

30 Jul 2015 07:01

RNS Number : 4818U
Port Erin Biopharma Investments Ltd
30 July 2015
 

7.00am 30 July 2015

Port Erin Biopharma Investments Limited

(the "Company")

 

Net Asset Value calculation to 30 June 2015

 

Jim Mellon, Chairman, commented: -

"The Net Asset Value ("NAV") calculation for the Company as at closing on 30 June 2015 was 11.47 pence per share, including un-invested cash of £255,564. The portfolio is valued under IFRS at bid price.

Net Assets stand at £2.7 million including Investments of £2.5 million. This quarter's NAV represents a decrease of 6.9% from the previous valuation of 12.32 pence per share, which included un-invested cash of £405,665. On this basis, no additional management fee is due to Shellbay Investments Limited.

The reported NAV to 30 June 2015 suffered due to some adverse foreign exchange fluctuations in our holdings on translation to the sterling reporting currency. The underlying value of our investments in unaffected by these accounting movements and has no cash impact. The portfolio continues to demonstrate strong fundamentals, including Plethora Solutions Holdings plc which enjoyed an uplift of 21% over the quarter."

 

 

 

Unaudited to 30 June 2015 £

Fixed Assets

 

 

 

Investments

2,454,953

Current Assets

 

 

 

Sundry Debtors

11,846

 

Uninvested cash

255,564

Current Liabilities

 

 

 

Creditors: amounts due

(61,600)

 

 

2,660,763

Capital and Reserves

 

 

 

Share Capital

23

 

Share Premium

1,890,142

 

Reserves

770,598

 

 

2,660,763

 

 

 

Shares in Issue

 

23,195,558

 

 

 

Net Asset Value per share

 

11.47 pence

 

 

 

Portfolio Details

 

Investments as at 30 June 2015

Value

% of Total Portfolio

 

 

 

 

 

Magna Biopharma Income Fund

£1,238,846

50.5%

 

Plethora Solutions Holdings

£310,000

12.6%

 

Summit Corporation

£408,150

16.6%

 

Other quoted holdings

£188,665

7.7%

 

Other unquoted holdings

£309,292

12.6%

 

Total

£2,454,953

100.0%

 

 

 

For further information, please contact:

 

Port Erin Biopharma

Investments Limited

Beaumont Cornish Limited

Peterhouse Capital Limited

The Company

Nomad

Broker

 

 

 

Denham Eke

(+44) (0) 1624 639396

Roland Cornish

(+44) (0) 207 628 3396

Lucy Williams

(+44) (0) 207 469 0936

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NAVFMGZNKLVGKZM
Date   Source Headline
26th Oct 20217:00 amRNSInSilico Medicine sale-Correction of sale proceeds
20th Oct 20218:00 amRNSAgronomics leads investment in California Cultured
12th Oct 20217:00 amRNSExercise of Warrants and Updated TVR
29th Sep 20217:00 amRNSAnnounces Sale of Oritain Shares
28th Sep 20217:00 amRNSNew Age Meats Announces US$ 25 million Series A
22nd Sep 20212:48 pmRNSPortfolio Company Update: Mosa Meat
20th Sep 20217:00 amRNSAgronomics leads VitroLabs Series A Funding
14th Sep 20217:00 amRNSPortfolio Company Update: Meatable
14th Sep 20217:00 amRNSPortfolio Company Update: BlueNalu
13th Sep 20218:00 amRNSSubscription in Formo’s US $50 million Fundraise
30th Jul 20215:34 pmRNSReplacement: Net Asset Valuation to 30 June 2021
30th Jul 202112:02 pmRNSNet Asset Value calculation to 31 June 2021
21st Jul 20211:15 pmRNSPortfolio Company Update: Shiok Meats Pte. Ltd
15th Jul 20217:00 amRNSWarrants to be traded on J P Jenkins
14th Jul 20217:00 amRNSTwo portfolio companies in XPRIZE semi-finals
13th Jul 20217:00 amRNSHalf Year Newsletter
25th Jun 20214:21 pmRNSPortfolio Company LIVEKINDLY Update
24th Jun 20215:03 pmRNSPortfolio Company Formo Update
24th Jun 20217:00 amRNSAnnounces the Sale of InSilico Medicine Inc Shares
28th May 202112:10 pmRNSResults of General Meeting, Issue of Equity & TVR
28th May 20217:00 amRNSAnnounces the Conversion of CellX SAFE
27th May 20217:00 amRNSBroker Option Results
25th May 20217:00 amRNSUpdate regarding Broker Option
20th May 20217:00 amRNSUpdate regarding Broker Option
13th May 20217:00 amRNSAnnounces Secondary Purchase of Shares in Meatable
12th May 20217:00 amRNSResult of Fundraising
11th May 202111:05 amRNSSecond Price Monitoring Extn
11th May 202111:00 amRNSPrice Monitoring Extension
11th May 202110:40 amRNSProposed Fundraise to raise £50 million
6th May 20212:30 pmRNSNew Consultancy Agreement with Shellbay
21st Apr 20218:30 amRNSInvestee Company Update: LegenDairy Foods
21st Apr 20217:00 amRNSNet Asset Value calculation to 31 March 2021
8th Apr 202110:47 amRNSInvestee Company Update: Solar Foods
30th Mar 20217:00 amRNSInvestee Company Update: LIVEKINDLY Fundraise
23rd Mar 20213:00 pmRNSMeatable Announces US$ 47 Million Financing
15th Mar 20212:06 pmRNSSecond Price Monitoring Extn
15th Mar 20212:01 pmRNSPrice Monitoring Extension
15th Mar 202111:05 amRNSSecond Price Monitoring Extn
15th Mar 202111:00 amRNSPrice Monitoring Extension
26th Feb 20217:00 amRNSPortfolio Company Update: LIVEKINDLY Collective
25th Feb 20217:00 amRNSAnnounces Further Investment in VitroLabs
18th Feb 20217:00 amRNSAnnounces Further Investment in Meatable
11th Feb 20217:00 amRNSInvestee Company Update: New Age Meats
3rd Feb 20217:00 amRNSResult of AGM
26th Jan 20217:00 amRNSHalf-year Report
20th Jan 20217:00 amRNSInvestee Company Update: BlueNalu Secures $60m
19th Jan 20213:33 pmRNSExercise of Warrants
18th Jan 20217:00 amRNSNet Asset Value calculation to 31 December 2020
16th Dec 20207:00 amRNSInvestment in SuperMeat
14th Dec 20207:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.